Clinical trial NCT02032602: Dry Needling on Myofascial Trigger Points in Older Adults With Nonspecific Shoulder Pain
Official title: Efficacy of Dry Needling on Myofascial Trigger Points in Adults Over 65 Years Old With Non-specific Shoulder Pain: Single Blind Randomized Controlled Clinical Trial
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Shoulder Pain
Keywords: Myofascial Pain Syndromes
Trigger Point
Shoulder Pain
Aged
Lead sponsor: University of Alcala
Sponsor class: OTHER
First posted: 2014-01-10
Enrollment: 66
Sex: ALL
Minimum age (years): 65
Standard ages: OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Background: Non-specific shoulder pain has a high prevalence in older adults and provokes functional alterations. Besides, there are difficulties for its clinical diagnosis, lack of effectiveness in the treatment and not much evidence is found regarding invasive physical therapy techniques in this population.

Purpose: To determine the efficacy of a single physical therapy intervention with deep dry needling on latent and active myofascial trigger points in older adults with non-specific shoulder pain.

Methods: Pilot Study, Single Blind Randomized Controlled Clinical Trial on 60 subjects aged 65 and over, will be diagnosed with nonspecific shoulder pain. The study will be approved by the Clinical Research Ethics Committee of the area. Sample will be recruited at their home and at a care center, and randomly will be distributed in Experimental Group (n=30), which will be received a session of Deep Dry Needling on an active and a latent Myofascial Trigger Points of the infraspinatus muscle; and Control Group (n=30), receiving a session of Deep Dry Needling only on an active Myofascial Trigger Point. A blind examiner will be evaluated Pain Intensity, Pain Pressure Threshold (anterior deltoid; extensor carpi radialis brevis) and Grip Strength, before, immediately after intervention and after a week of treatment.


Eligibility criteria: Inclusion Criteria:

* people aged 65 or over with uni or bilateral non-specific shoulder pain and with at least one active and one latent MTrP in the infraspinatus homolateral to the painful shoulder

Exclusion Criteria:

* prior diagnosis of myopathy or neuropathy; cognitive deficit in the medical record; cervical spine, rotator cuff tendons or glenohumeral joint problems in the medical record; corticoid infiltration or local anaesthetic during the previous year or during follow-up; surgical procedure affecting the upper limb or preceding cervical; ingestion of antiaggregant, anti-coagulant, analgesic or anti-inflammatory medication or abusive substances in the week prior to treatment and during follow-up were excluded from the study

Primary outcomes:
measure: Change from baseline in Pain Intensity on the Numerical Rating Scale (NRS) at 5 minutes
timeFrame: Baseline, 5 minutes
measure: Change from baseline in Pain Pressure Threshold of anterior deltoid at 5 minutes
timeFrame: Baseline, 5 minutes
measure: Change from baseline in Maximum Grip Strength at 5 minutes
timeFrame: Baseline, 5 minutes
measure: Change from baseline in Pressure Pain Threshold of extensor carpi radialis brevis at 5 minutes
timeFrame: Baseline, 5 minutes
measure: Change from baseline in Pain Intensity on the Numerical Rating Scale (NRS) at 1 week
timeFrame: Baseline, 1 week
measure: Change from baseline in Pressure Pain Threshold of anterior deltoid at 1 week
timeFrame: Baseline,1 week
measure: Change from baseline in Maximum Grip Strength at 1 week
timeFrame: Baseline, 1 week
measure: Change from baseline in Pressure Pain Threshold of extensor carpi radialis brevis at 1 week
timeFrame: Baseline, 1 week
Secondary outcomes:
Other outcomes:
Locations:
city: Alcala de Henares
country: Spain
facility: University of Alcala
state: Madrid
Study officials:
References: